Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Oppenheimer Holdings (OPY) Research & Development (2016 - 2026)

Oppenheimer Holdings' Research & Development history spans 17 years, with the latest figure at $26.6 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 1.47% to $26.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $106.2 million, a 5.14% increase, with the full-year FY2025 number at $105.8 million, up 6.45% from a year prior.
  • Research & Development hit $26.6 million in Q1 2026 for Oppenheimer Holdings, down from $27.4 million in the prior quarter.
  • Over the last five years, Research & Development for OPY hit a ceiling of $27.4 million in Q4 2025 and a floor of $20.9 million in Q2 2022.
  • Historically, Research & Development has averaged $24.0 million across 5 years, with a median of $24.6 million in 2024.
  • Biggest five-year swings in Research & Development: rose 9.52% in 2024 and later increased 1.47% in 2026.
  • Tracing OPY's Research & Development over 5 years: stood at $21.5 million in 2022, then increased by 9.38% to $23.5 million in 2023, then rose by 8.48% to $25.5 million in 2024, then increased by 7.63% to $27.4 million in 2025, then decreased by 3.21% to $26.6 million in 2026.
  • Business Quant data shows Research & Development for OPY at $26.6 million in Q1 2026, $27.4 million in Q4 2025, and $25.9 million in Q3 2025.